Core Viewpoint - Rosen Law Firm has initiated a class action lawsuit against PomDoctor Ltd. (NASDAQ: POM) on behalf of investors who purchased securities between October 9, 2025, and December 11, 2025, alleging that the company misled investors regarding its business operations [1]. Group 1: Allegations Against PomDoctor Ltd. - The lawsuit claims that PomDoctor was involved in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [1]. - It is alleged that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [1]. - The company's public statements and risk disclosures reportedly omitted any mention of false rumors and artificial trading activity that influenced the stock price [1]. - As a result of these actions, the positive statements made by the defendants about PomDoctor's business, operations, and prospects were materially misleading and lacked a reasonable basis [1]. Group 2: Class Action Participation - Shareholders interested in serving as lead plaintiffs must file their motions with the court by April 7, 2026 [1]. - A lead plaintiff acts on behalf of other class members in directing the litigation, but participation is not required to be eligible for recovery [1]. - All representation in this case is on a contingency fee basis, meaning shareholders will not incur any fees or expenses [1].
Rosen Law Firm Urges PomDoctor Ltd. (NASDAQ: POM) Stockholders to Contact the Firm for Information About Their Rights